An Open-Label Extension Trial to Assess the Safety and Tolerability of Long Term Treatment of Rotigotine in Subjects With Idiopathic Parkinson's Disease
Clinical trial NCT00505687 · COMPLETED
Trial details
- NCT number
- NCT00505687
- Sponsor
- UCB Pharma
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-02-01
- Primary completion
- 2008-12-01
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.